BioNTech
BNTX
95.25
-0.48
-0.50%
BioNTech
US · BNTX
#801 by market cap
Listed 2019
95.25
-0.48
-0.50%
Live - 5344 symbols - heartbeat 204s ago
· 2026-10-08 07:37
Pre-market
94.26
-1.04%
After-hours
96.00
+0.79%
Overnight
95.00
-0.26%
- Market cap
- 23.93B
- P/E (TTM)i
- -12.68
- P/Bi
- 1.20
- EPSi
- -5.26
- Div yieldi
- 0.00%
- 52W posi
- 35%
Reader sentiment
Are you bullish or bearish on BNTX?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 14 analysts
Buy
Avg price target
126.85 +33.2%
Price target rangecurrent 95.25
Low96.00
Avg126.85
High140.00
Buy 79%
Hold 21%
Sell 0%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-09-24 | Wells Fargo | -- | BUY | 140.00 |
| 2026-09-23 | CCORF | -- | BUY | 136.00 |
| 2026-09-21 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-09-16 | UBS | -- | BUY | 135.00 |
| 2026-09-15 | CCORF | -- | BUY | 136.00 |
| 2026-09-15 | Berenberg Bank | -- | BUY | 140.00 |
| 2026-09-15 | Jefferies | -- | BUY | 138.00 |
| 2026-09-14 | BofA Securities | -- | BUY | 122.00 |
| 2026-09-14 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-09-14 | BMO Capital | -- | HOLD | 105.00 |
| 2026-09-14 | Goldman Sachs | -- | BUY | 127.00 |
| 2026-09-08 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-09-08 | BMO Capital | -- | HOLD | 105.00 |
| 2026-09-04 | Goldman Sachs | -- | BUY | 127.00 |
| 2026-08-31 | CCORF | -- | BUY | 136.00 |
| 2026-08-31 | Morgan Stanley | -- | BUY | 115.00 |
| 2026-08-31 | Citi | -- | BUY | 125.00 |
| 2026-08-28 | BMO Capital | -- | BUY | 128.00 |
| 2026-08-26 | Deutsche Bank | -- | BUY | 140.00 |
| 2026-08-20 | CCORF | -- | BUY | 142.00 |
| 2026-08-20 | Jefferies | -- | BUY | 138.00 |
| 2026-08-19 | Wells Fargo | -- | BUY | 140.00 |
| 2026-08-19 | J.P. Morgan | -- | HOLD | -- |
| 2026-08-18 | CCORF | -- | BUY | 142.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1
■ Upgrades■ Downgrades
- 0 upgrades vs 1 downgrade among tracked analyst rating changes.
- Most recent: BMO Capital moved from Buy to Hold on 2026-09-08.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-09-08 | BMO Capital | BUY → HOLD | 105.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-08-04 | -- | ±7.30% | -0.98% (in line) |
| 2026/Q1 | 2026-05-05 | -- | ±7.38% | -3.88% (in line) |
| 2025/Q4 | 2026-03-10 | -- | ±6.66% | -17.88% (beat) |
| 2025/Q3 | 2025-11-03 | -- | ±7.06% | +0.04% (in line) |
| 2025/Q2 | 2025-08-04 | -- | ±8.63% | +2.51% (in line) |
| 2025/Q1 | 2025-05-05 | -- | ±10.75% | -3.66% (in line) |
| 2024/Q4 | 2025-03-10 | -- | ±10.78% | -3.15% (in line) |
| 2024/Q3 | 2024-11-04 | -- | ±9.54% | -2.25% (in line) |
| 2024/Q2 | 2024-08-05 | -- | ±6.25% | -4.45% (in line) |
| 2024/Q1 | 2024-05-06 | -- | ±6.40% | +0.68% (in line) |
| 2023/Q4 | 2024-03-20 | -- | ±10.06% | -4.38% (in line) |
| 2023/Q3 | 2023-11-06 | -- | ±8.60% | +4.10% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:37:10 · For reference only, not investment advice and not tailored to your situation.